ARTICLE | Management Tracks
Zaks, Gujrathi join OrbiMed
Plus: BioTheryX, BioCryst, Redx, Tango, Epizyme and more
November 2, 2021 12:57 AM UTC
Tal Zaks and Sheila Gujrathi joined healthcare investment firm OrbiMed Advisors LLC as venture partner and adviser, respectively. Zaks was previously CMO of Moderna Inc. (NASDAQ:MRNA). Gujrathi was previously CEO and co-founder of Gossamer Bio Inc. (NASDAQ:GOSS).
Philippe Drouet became president and CEO at BioTheryX Inc., a protein degradation company. Drouet, a 14-year veteran of Novartis AG (SIX:NOVN; NYSE:NVS), was chief commercial officer at CRISPR Therapeutics AG (NASDAQ:CRSP), before which he was SVP of global oncology at Merck & Co. Inc. (NYSE:MRK)...